Market Overview

Gabelli Maintains Buy on Cameco


Gabelli is out with its report today on Cameco (NYSE: CCJ), maintaining Buy.

In its report, Gabelli writes, "We reiterate our buy recommendation: Cameco is a leading uranium producer with a diverse group of high-grade, low-cost operations spread throughout the Americas, Asia and Australia. The offer to acquire Hathor confirms Cameco's long-term commitment to uranium production and strengthens its ability to supply world markets as uranium demand increases with nuclear power generation growth. CCJ is trading at a 37% discount to our 2012 PMV of $35 per share."

At the time of posting, shares of CCJ were trading pre-market at $22.50, up 0.85% from Friday's close.


Related Articles (CCJ)

View Comments and Join the Discussion!

Posted-In: GabelliAnalyst Color Analyst Ratings

Latest Ratings

TSLAJP MorganMaintains125.0
INTCTruist SecuritiesMaintains64.0
FBTruist SecuritiesMaintains320.0
AAPLCowen & Co.Maintains153.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at